204 related articles for article (PubMed ID: 36166080)
1. Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor.
Zwezerijnen GJC; Eertink JJ; Ferrández MC; Wiegers SE; Burggraaff CN; Lugtenburg PJ; Heymans MW; de Vet HCW; Zijlstra JM; Boellaard R
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):486-493. PubMed ID: 36166080
[TBL] [Abstract][Full Text] [Related]
2. Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.
Kramer GM; Frings V; Hoetjes N; Hoekstra OS; Smit EF; de Langen AJ; Boellaard R
J Nucl Med; 2016 Sep; 57(9):1343-9. PubMed ID: 27103020
[TBL] [Abstract][Full Text] [Related]
3. Reproducibility of Standardized Uptake Values Including Volume Metrics Between TOF-PET-MR and TOF-PET-CT.
Tanaka A; Sekine T; Ter Voert EEGW; Zeimpekis KG; Delso G; de Galiza Barbosa F; Warnock G; Kumita SI; Veit Haibach P; Huellner M
Front Med (Lausanne); 2022; 9():796085. PubMed ID: 35308500
[TBL] [Abstract][Full Text] [Related]
4. Influence of scan time point and volume of intravenous contrast administration on blood-pool and liver SUVmax and SUVmean in [18F] FDG PET/CT.
Schoen M; Braun T; Manava P; Ludwigs S; Lell M
Nuklearmedizin; 2018 Apr; 57(2):50-55. PubMed ID: 29590675
[TBL] [Abstract][Full Text] [Related]
5. Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors.
Benz MR; Evilevitch V; Allen-Auerbach MS; Eilber FC; Phelps ME; Czernin J; Weber WA
J Nucl Med; 2008 Jul; 49(7):1038-46. PubMed ID: 18552153
[TBL] [Abstract][Full Text] [Related]
6. The value on SUV-derived parameters assessed on
Liao X; Liu M; Li S; Huang W; Guo C; Liu J; Xiong Y; Zhang J; Fan Y; Wang R
BMC Med Imaging; 2023 Apr; 23(1):49. PubMed ID: 37020286
[TBL] [Abstract][Full Text] [Related]
7. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
Williams JM; Rani SD; Li X; Arlinghaus LR; Lee TC; MacDonald LR; Partridge SC; Kang H; Whisenant JG; Abramson RG; Linden HM; Kinahan PE; Yankeelov TE
Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582
[TBL] [Abstract][Full Text] [Related]
8. Consistency of metabolic tumor volume of non-small-cell lung cancer primary tumor measured using 18F-FDG PET/CT at two different tracer uptake times.
Liu H; Chen P; Wroblewski K; Hou P; Zhang CP; Jiang Y; Pu Y
Nucl Med Commun; 2016 Jan; 37(1):50-6. PubMed ID: 26426969
[TBL] [Abstract][Full Text] [Related]
9. Comparison of PET/CT SUV metrics across different clinical software platforms.
Wilson CM; Selwyn RG; Elojeimy S
Clin Imaging; 2022 Sep; 89():104-108. PubMed ID: 35777237
[TBL] [Abstract][Full Text] [Related]
10. Lymph node standardized uptake values at pre-treatment
Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-induced Cardiac18F-FDG Uptake in Patients with Lymphoma: An Early Metabolic Index of Cardiotoxicity?
Dourado MLC; Dompieri LT; Leitão GM; Mourato FA; Santos RGG; Almeida Filho PJ; Markman Filho B; Melo MDT; Brandão SCS
Arq Bras Cardiol; 2022; 118(6):1049-1058. PubMed ID: 35703659
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Tumor Burden Assessed by Dual Time Point [
Garcia-Vicente AM; Pérez-Beteta J; Pérez-García VM; Molina D; Jiménez-Londoño GA; Soriano-Castrejón A; Martínez-González A
Mol Imaging Biol; 2017 Aug; 19(4):636-644. PubMed ID: 27981471
[TBL] [Abstract][Full Text] [Related]
13. The Association Between Liver and Tumor [
Wu X; Bhattarai A; Korkola P; Pertovaara H; Eskola H; Kellokumpu-Lehtinen PL
Mol Imaging Biol; 2017 Oct; 19(5):787-794. PubMed ID: 28144908
[TBL] [Abstract][Full Text] [Related]
14. Mitigating SUV uncertainties using total body PET imaging.
Smith CLC; Zwezerijnen GJC; den Hollander ME; Weijland J; Yaqub M; Boellaard R
Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1070-1078. PubMed ID: 37953391
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the quantitative measurement of 18F-FDG PET/CT and histopathological findings in IgG4-related disease.
Tsuji S; Iwamoto N; Horai Y; Fujikawa K; Fujita Y; Fukui S; Ideguchi R; Michitsuji T; Nishihata S; Okamoto M; Tsuji Y; Endo Y; Shimizu T; Sumiyoshi R; Koga T; Kawashiri SY; Igawa T; Ichinose K; Tamai M; Nakamura H; Origuchi T; Kudo T; Kawakami A
Clin Exp Rheumatol; 2021; 39(6):1338-1344. PubMed ID: 33506750
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET/MR imaging of lymphoma nodal target lesions: Comparison of PET standardized uptake value (SUV) with MR apparent diffusion coefficient (ADC).
Bernstine H; Domachevsky L; Nidam M; Goldberg N; Abadi-Korek I; Shpilberg O; Groshar D
Medicine (Baltimore); 2018 Apr; 97(16):e0490. PubMed ID: 29668631
[TBL] [Abstract][Full Text] [Related]
17. Relationships of body habitus and SUV indices with signal-to-noise ratio of hepatic (18)F-FDG PET.
Keramida G; Dunford A; Siddique M; Cook GJ; Peters AM
Eur J Radiol; 2016 May; 85(5):1012-5. PubMed ID: 27130064
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.
Pak K; Kim BS; Kim K; Kim IJ; Jun S; Jeong YJ; Shim HK; Kim SD; Cho KS
Am J Otolaryngol; 2018; 39(1):1-5. PubMed ID: 29056243
[TBL] [Abstract][Full Text] [Related]
19. Effects of rigid and non-rigid image registration on test-retest variability of quantitative [18F]FDG PET/CT studies.
van Velden FH; van Beers P; Nuyts J; Velasquez LM; Hayes W; Lammertsma AA; Boellaard R; Loeckx D
EJNMMI Res; 2012 Mar; 2(1):10. PubMed ID: 22404895
[TBL] [Abstract][Full Text] [Related]
20. Is the standard uptake value (SUV) appropriate for quantification in clinical PET imaging? - Variability induced by different SUV measurements and varying reconstruction methods.
Brendle C; Kupferschläger J; Nikolaou K; la Fougère C; Gatidis S; Pfannenberg C
Eur J Radiol; 2015 Jan; 84(1):158-162. PubMed ID: 25467224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
